Arrowhead Publishers, Nov 2009
resection, drug therapy plays a vital role in the management of lungcancer. Such high level of unmet need ensures the lungcancer market is an attractive commercial opportunity for new drug development
Arrowhead Publishers, Aug 2008, Pages: 318
the markets for colorectal cancer, prostate cancer, lungcancer, breast cancer, leukemia and non-Hodgkin’s lymphoma. Therapies for other types of cancer are discussed throughout the report, but are limited
Jain PharmaBiotech, Feb 2012, Pages: 1008
of cancer
ESC vaccine for prevention of lungcancer
Genetic modification of stem cells for cancertherapy
Genetic modification of hematopoietic stem cells
Use of hematopoietic stem cells to deliver suicide
Global Industry Analysts, Inc., July 2009, Pages: 842
. Executive Summary
1. MARKET OVERVIEW II-1
LungCancer Therapeutics - Driven by Next Generation Drugs II-1
New Therapies Drive NSCLC Market II-1
Market Value of Taxanes to Decrease by 2015 II-2
Lung
Expert Reviews Ltd, June 2011, Pages: 210
of involves surgery, removal of the draining lymph nodes, radiotherapy, hormone therapy and treatment with cytotoxic drugs.
Advances in the identification and understanding of antigens, cytokines
Arrowhead Publishers, Dec 2005, Pages: 261
.
The market for the pharmaceutical treatment of lungcancer is still largely dominated by cytotoxics in 2005-2006, although targeted therapies are beginning to make an impact. Continued uptake of Tarceva and potential approvals
Global Industry Analysts, Inc., Oct 2011, Pages: 897
to drive cancertherapy market in the future. Currently approved combination therapies include paclitaxel, and carboplatin together with Avastin indicated for the treatment of non-small cell lungcancer
Decision Resources, Inc., Dec 2009, Pages: 38
Cancer Society, National Cancer Act (P.L. 92–218), number of deaths, number of new cases, 1,166 cancer R&D projects, biologics, targeted agents, vaccines, cytotoxictherapies, chemotherapies, targeted
Arrowhead Publishers, Oct 2004, Pages: 233
Market
6.1 Current Treatment of LungCancer
Table 6.1 Stages of LungCancer
6.1.1 Surgery
6.1.2 Cytotoxics
6.1.3 Radiation Therapy
6.2 An Overview of the Market for LungCancerTherapies
Datamonitor, Dec 2010, Pages: 167
. By contrast, cytotoxictherapies and immunotherapeutic/immunomodulatory drugs (including therapeutic cancer vaccines) account for only 13% of the pipeline each.
- The treatment of non-small cell lungcancer
Jain PharmaBiotech, Feb 2012, Pages: 276
Role of NO in drug resistance of cancer
Role of NO in treatment of brain tumors
NO-induced apoptosis
Role of NO in antiangiogenesis therapies in cancer
NO donors for the treatment of cancer
Jain PharmaBiotech, Feb 2012, Pages: 772
nanoparticles
Cytotoxic effects of cancer nanoparticles
Nanoshell-based cancertherapy
Nanoshells for thermal ablation of cancer
Nanobody-based cancertherapy
Nanoparticles for targeting tumors
Nanocarriers
TriMark Publications, May 2008, Pages: 182
for Lymphoma 109
Table 5.21: U.S. Sales of Rituxan, 1999-2005 111
Table 5.22: Cytotoxics for LungCancerTherapy 115
Table 5.23: Anti-Angiogenics for LungCancer 115
Table 5.24: Drugs in Development for Lung
Global Industry Analysts, Inc., April 2009, Pages: 739
II-48
Doxazosin, a Cytotoxic Drug for Prostate Cancer II-49
Radiation Therapy II-49
Strategies to Enhance
John Wiley and Sons Ltd, Dec 2009, Pages: 424
of distinctive symptoms makes early diagnosis difficult
Lungcancer is often diagnosed at an advanced stage
There are two main categories of lungcancer
Three traditional therapies are used in lungcancer
Global Industry Analysts, Inc., Oct 2006, Pages: 387
This report analyzes the worldwide markets for Colorectal Cancer Therapeutics in US$ Million. The major product segments analyzed are CytotoxicTherapies (5-FU (Fluorouracil), Camptosar (Irinotecan
Frost & Sullivan, Jan 2007, Pages: 115
This study provides a comprehensive overview of the commercial market for lung, breast and colorectal cancer medicines responding to both cytotoxic and hormonal therapies. Researched countries
Bioseeker, Aug 2006, Pages: 228
and pitfalls
Research and analysis highlights
Among the targeted therapies for cancer, immunotherapy is probably the most versatile treatment strategy for the eradication of tumors, metastatic spread
